Filing Details

Accession Number:
0001209191-10-053181
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-04 13:00:00
Reporting Period:
2010-11-04
Filing Date:
2010-11-04
Accepted Time:
2010-11-04 16:28:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1018535 L Walter Robb C/O Celgene Corporation
86 Morris Avenue
Summit NJ 07901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-04 5,900 $44.94 8,584 No 4 M Direct
Common Stock Disposition 2010-11-04 5,900 $62.38 2,684 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-11-04 5,900 $0.00 5,900 $44.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,433 2019-06-17 No 4 M Direct
Footnotes
  1. The option was fully exercisable.
  2. Option granted pursuant to the Company's 2008 Stock Incentive Plan.